Niche CRO Small specialized viral diagnostic and research lab offering contract research services including BSL3 for SARS-CoV-2 and Powassan Virus, and BSL2 for HHV-6A/B, EBV, CMV, HHV-7, presenting a precise target for academic medical centers, children's hospitals, infertility clinics, and integrative healthcare providers.

Clinical Testing Offerings include clinical tests such as ci-HHV-6 and HHV-6 immunohistochemistry, indicating potential upsell to institutions needing molecular diagnostics and histopathology services alongside contract research.

Growth Signals Revenue range indicates modest scale with room to expand through multi-institution contracts, expanded biosafety capabilities, and broadened testing panels, suggesting opportunities for larger research collaborations or repeat business.

Tech-Driven Presence of modern web and form tools (WordPress plugins, forms, and hosted services) suggests scalable outreach and digital lead capture potential; leverage for targeted outreach to bioscience R&D and hospital purchasing teams.

Competitive Positioning Compared to large contract research players, Coppe Laboratories operates with specialized BSL facilities and targeted viral panel capabilities, enabling personalized service for niche clients who require rapid, compliant viral testing and diagnostics.